Standard health insurance in Europe and North America does not cover experimental stem-cell therapies for muscular dystrophy. Most insurers classify these treatments as investigational and decline reimbursement. Private out-of-pocket payment is required at dedicated clinics, typically €4,000–8,000 per cycle. Clinical-trial participation occasionally offers free or subsidised access to active drug. Some rare-disease foundations or research charities may provide partial financial assistance for qualifying patients enrolled in legitimate trials. Patients should contact their insurer and disease advocacy groups to explore funding options before committing to private treatment.
Muscular dystrophy treatment costs typically range €4,000–7,500 per cycle, reflecting the need for multiple infusions and specialist neuromuscular assessment. Placental MSC sourcing and expansion for systemic administration incurs higher manufacturing expense than single-injection protocols. Disease severity and muscle group involvement influence whether local or systemic delivery is elected, affecting total cost. Many programmes require baseline and follow-up neuroimaging and strength testing, adding to overall expenses. European centres generally charge at the lower end of the range for research-protocol participation, whilst private clinics may exceed €8,000 per session.
我是候选人吗？ → · Muscular Dystrophy: full overview → · 肌肉营养不良成本 → · Cost →
由 StemCellAtlas 的编辑团队进行医学审查，与Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估